A Multicentre Open-label Dose Escalation Tiral of Zanolimumab in Combination With CHOP Chemotherapy in Patients With CD4 Positive Non-cutaneous Peripheral T-cell Lymphoma With Nodal Involvement.
Phase 2
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
T-cell Lymphoma
Both
T-cell Lymphoma
Trial Information
A Multicentre Open-label Dose Escalation Tiral of Zanolimumab in Combination With CHOP Chemotherapy in Patients With CD4 Positive Non-cutaneous Peripheral T-cell Lymphoma With Nodal Involvement.
Inclusion Criteria:
- study is closed to enrollment
Exclusion Criteria:
- study is closed to enrollment
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Authority:
Netherlands: Medicines Evaluation Board (MEB)
Study ID:
GEN112
NCT ID:
NCT00893516
Start Date:
May 2007
Completion Date:
December 2008
Related Keywords:
- T-Cell Lymphoma
- non cutaneous peripheral t-cell lymphoma with nodal involvement
- Lymphoma
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Peripheral
Name | Location |
|---|
